GRACE THERAPEUTICS INC

GRCE · NASDAQ

Updated at 2026-10-15 08:28:24

$1.89-5.02%
Today's High
$2.01
Today’s Low
$1.84
GRACE THERAPEUTICS INC (GRCE) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.97
Previous Close
$1.89
Volume
177.97K
Market Cap
$39.75M
P/E Ratio
--
EPS
$-1.17

Previous Day Range

$1.84$2.01

52-Week Range

$1.79$5.18

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
103 CARNEGIE CENTER, PRINCETON, NJ, UNITED STATES, 08540
Country
US
Listing Date
2013-03-07
Fiscal Year End
March
Shares Outstanding
16.27M
CIK
0001444192

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company is headquartered in Princeton, New Jersey.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$15.79M

2026-03-31

$3M

2025-12-31

$3.36M

2025-09-30

$3.52M

Net Income

2026-06-30

-$15.79M

2026-03-31

-$1.17M

2025-12-31

-$3.17M

2025-09-30

-$1.3M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.91

2026-03-31

$-0.08

2025-12-31

$-0.19

2025-09-30

$-0.08

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$15.78M

2026-03-31

-$3M

2025-12-31

-$3.35M

2025-09-30

-$3.52M

Effective Tax Rate

2026-06-30

--

2026-03-31

59.06%

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.